Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

18.38USD
5:43pm GMT
Change (% chg)

$-0.10 (-0.54%)
Prev Close
$18.48
Open
$19.00
Day's High
$19.00
Day's Low
$17.90
Volume
3,781
Avg. Vol
7,010
52-wk High
$21.71
52-wk Low
$5.70

Latest Key Developments (Source: Significant Developments)

Acer Therapeutics Announces Closing Of Underwritten Public Offering Of Common Stock
Thursday, 14 Dec 2017 

Acer Therapeutics Inc ::ACER THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.  Full Article

Acer Therapeutics Announces Pricing Of Underwritten Public Offering Of Common Stock
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.ACER THERAPEUTICS INC - ANNOUNCED PRICING OF ITS UNDERWRITTEN PUBLIC OFFERING OF 916,667 SHARES OF COMMON STOCK AT $12.00/SHARE.  Full Article

Acer Therapeutics Announces Proposed Underwritten Public Offering Of Common Stock
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.ACER THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING TO FUND RESEARCH AND DEVELOPMENT EFFORTS, TO SEEK REGULATORY APPROVAL FOR EDSIVO.ACER THERAPEUTICS INC - ALSO INTENDS TO USE NET PROCEEDS FROM OFFERING TO INVEST IN PRE-COMMERCIAL ACTIVITIES FOR EDSIVO, AMONG OTHERS.  Full Article

Acer Therapeutics Q3 loss per share $1.09
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Acer Therapeutics Inc ::Acer Therapeutics reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $1.09.  Full Article

Opexa Therapeutics reports Q2 loss per share $0.30
Thursday, 11 Aug 2016 

Opexa Therapeutics Inc : Opexa Therapeutics reports second quarter 2016 financial results and provides corporate update . Q2 loss per share $0.30 .Q2 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S.  Full Article

Opexa Therapeutics Q1 loss per share $0.31
Thursday, 12 May 2016 

Opexa Therapeutics Inc : Opexa therapeutics reports first quarter 2016 financial results and provides corporate update .Q1 loss per share $0.31.  Full Article

BRIEF-Acer Therapeutics Announces Closing Of Underwritten Public Offering Of Common Stock

* ACER THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: